Molecular Constructor on the Basis of Barnase–Barstar Module
ISSN 1068-1620, Russian Journal of Bioorganic Chemistry, 2009, Vol. 35, No. 6, pp. 685–701. © Pleiades Publishing, Ltd., 2009. Original Russian Text © S.M. Deev, E.N. Lebedenko, 2009, published in Bioorganicheskaya Khimiya, 2009, Vol. 35, No. 6, pp. 761–778. Antibody Engineering: Molecular Constructor on the basis of Barnase–Barstar Module S. M. Deev1 and E. N. Lebedenko Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, Moscow, 117997 Russia Received May 19, 2009; in final form, May 29, 2009 Abstract—Today, antibody engineering for clinical applications is a rapidly progressing field of science and a big business. The basic functions of an antibody can be spatially differentiated and attributed to various struc- tural domains of a molecule. Therefore, each of them may be an object for engineering with the aim of using a definite antibody function. In this sense, the potential of antibodies is unique. In this article, recent achieve- ments and current problems of antibody engineering are briefly reviewed. The main attention is focused on a molecular constructor that allows for obtaining, with the help of a versatile barnase–barstar module, mono- and multivalent miniantibodies and their derivatives with outlined properties. Key words: single chain antibodies, multivalency, bispecificity, targeted delivery, barnase–barstar module DOI: 10.1134/S1068162009060041 INTRODUCTION mAbs), active or diagnostic agents, for instance, cytok- ines, protein toxins and radioisotopes, enzymes, fluo- Currently, antibodies have the second largest pro- rescent proteins, etc. duction value in the pharmaceutical market after vac- cines. More than 85% of antibodies permitted for clin- The current review will focus on a molecular con- ical use are products of antibody engineering.
[Show full text]